Spero Therapeutics Announces Fourth Quarter and Full-Year 2020 Operating Results and Provides Business Update

NEXT STORY
Family of Bob Marley and Silo Wellness Collaborate to Debut Exclusive Worldwide Functional & Psychedelic Mushroom Brand
PREV STORY
ContraFect Announces BARDA Contract Award for Up to $86.8 Million and Provides Business Outlook
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oxford Biomedica Announces that Boehringer Ingelheim has Exercised Option Relating to a Novel Gene Therapy Treatment for Cystic Fibrosis

author_avatar
NASDAQ Market News

Présentation de Données Issues de l’Essai COAST Comprenant Monalizumab au Congrès de l’ESMO 2021

author_avatar
NASDAQ Market News

Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection

AUSTIN, Texas, May 29, 2018 (GLOBE NEWSWIRE) -- Savara, Inc. (NASDAQ:SVRA), an orphan lung ...

author_avatar
NASDAQ Market News